Search Results for keywords:"analytical testing"

Found 4 results

Search Results: keywords:"analytical testing"

💰 Only
Oldest Newest
  • 2024-30948 — Dietary Supplement Laboratory Quality Assurance Program (DSQAP) Consortium
    💰
    Type:Notice
    Citation:89 FR 105535
    Reading Time:about 5 minutes

    The National Institute of Standards and Technology (NIST) is setting up a new program called the Dietary Supplement Laboratory Quality Assurance Program (DSQAP) Consortium. This program aims to improve the accuracy and safety of dietary supplements by developing better testing and measurement methods. NIST is inviting organizations to join the Consortium by sharing their expertise, like analytical testing skills or unique industry knowledge, on a voluntary basis. Participants will sign a Cooperative Research and Development Agreement (CRADA), though non-CRADA options exist for those unable to enter such agreements due to legal or governmental constraints.

    Simple Explanation

    NIST is starting a new team to help make dietary supplements safer by improving the tests for them. They want people who know a lot about supplements to join, and they'll all have to agree on certain rules to be part of the team.

  • 2021-00647 — Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
    Type:Notice
    Citation:86 FR 3197
    Reading Time:about a minute or two

    IsoSciences, LLC has applied to the Drug Enforcement Administration to become a bulk manufacturer of certain controlled substances. They plan to create synthetic versions of Marihuana and Tetrahydrocannabinols for use in analytical testing, and no other activities for these drugs are permitted with this registration. The public has until March 15, 2021, to submit written comments or objections, or to request a hearing regarding this application.

    Simple Explanation

    IsoSciences, LLC wants to make pretend versions of some special plants and substances to help scientists test them. People have until March 15, 2021, to say if they agree or disagree with this plan.

  • 2021-03834 — Importer of Controlled Substances Application: Globyz Pharma, LLC
    Type:Notice
    Citation:86 FR 11333
    Reading Time:about a minute or two

    Globyz Pharma, LLC has applied to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances for analytical testing. The application does not authorize any other activities, such as importing FDA-approved finished dosage forms for sale. Interested parties, including registered manufacturers, can submit comments or objections, or request a hearing regarding this application by March 26, 2021. The DEA's decision will be based on alignment with legal requirements under 21 U.S.C. 952(a)(2).

    Simple Explanation

    Globyz Pharma, a company, wants permission to bring in special medicines for testing, but they can't sell the medicines. People can share their thoughts or ask for a meeting to talk about it before the end of March 2021.

  • 2025-01707 — Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
    Type:Notice
    Citation:90 FR 8154
    Reading Time:about a minute or two

    VHG Labs, doing business as LGC Standards, has applied to the Drug Enforcement Administration (DEA) to register as an importer of specific controlled substances for analytical testing purposes. The DEA has announced this in the Federal Register and is accepting comments or objections from registered bulk manufacturers and other interested parties until February 24, 2025. Requests for a hearing related to this application must also be sent to the DEA by this date. The authorization sought does not include the importation of finished dosage forms approved by the Food and Drug Administration for commercial sale.

    Simple Explanation

    VHG Labs wants permission to bring in special chemicals for testing, and people have a month to say if they agree or not. These chemicals aren't for making medicines you can buy at the store.